Statistical evaluation of CZE-UV and CZE-ESI-MS data of intact α-1-acid glycoprotein isoforms for their use as potential biomarkers in bladder cancer.
α-1-acid glycoprotein (AGP) is a highly heterogeneous protein that presents a vast number of isoforms (molecules of the protein differing in its peptidic and/or glycosidic moieties). In the last years, several authors have studied the potential use of AGP as a cancer biomarker. These studies focus on the correlation of different features of AGP structure (i.e. fucosylation, antennarity) with cancer or on the total protein blood concentration. In this study, the potential of CZE-UV and CZE-ESI-MS analysis of intact AGP isoforms to study the correlation of this protein with bladder cancer is shown. Samples from 16 individuals (eight healthy, eight bladder cancer) were analyzed and characterized in great detail including data on intact protein isoforms and on released glycans. The analytical data were evaluated employing different statistical techniques (ANOVA; principal component analysis, PCA; linear discriminant analysis; and partial least squares-discriminant analysis). Statistical differences between the two groups of study were observed. The best results were obtained by linear discriminant analysis of the CZE-ESI-MS data for intact AGP isoforms (93.75% of correct classification). Due to MS characterization, it can be observed that differences between the samples are mainly due to higher abundance of AGP isoforms containing tri- and tetra-antennary fucosylated oligosaccharides in cancer patients. The results show the great potential of CE-MS in combination with advanced data processing for the use of intact protein isoforms as disease biomarkers.
Institute of Organic Chemistry (CSIC), Madrid, Spain.
Sara
S
Ongay
Pedro J
PJ
Martín-Álvarez
Christian
C
Neusüss
Mercedes
M
de Frutos
D000704:Analysis of Variance; D014408:Biomarkers, Tumor / Q000097:blood / Q000737:chemistry / Q000302:isolation & purification*; D016002:Discriminant Analysis; D019075:Electrophoresis, Capillary / Q000379:methods*; D006801:Humans; D009961:Orosomucoid / Q000032:analysis / Q000737:chemistry / Q000302:isolation & purification*; D025341:Principal Component Analysis; D020033:Protein Isoforms; D012016:Reference Values; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods; D001749:Urinary Bladder Neoplasms / Q000097:blood*
D014408:Biomarkers, Tumor; D009961:Orosomucoid; D020033:Protein Isoforms